{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:19:55Z","timestamp":1791595195274,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,1,18]],"date-time":"2008-01-18T00:00:00Z","timestamp":1200614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s00415-008-0731-z","type":"journal-article","created":{"date-parts":[[2008,1,16]],"date-time":"2008-01-16T18:01:59Z","timestamp":1200506519000},"page":"526-531","source":"Crossref","is-referenced-by-count":29,"title":["Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy"],"prefix":"10.1007","volume":"255","author":[{"given":"C.","family":"Kraemer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Nolting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Arendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. W.","family":"Husstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,18]]},"reference":[{"key":"731_CR1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/AAC.41.3.587","volume":"41","author":"Andrei","year":"1997","unstructured":"Andrei G, Snoeck R, Vandeputte M, De Clercq E (1997) Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 41:587\u2013593","journal-title":"Antimicrob Agents Chemother"},{"key":"731_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13550280390195388","volume":"9","author":"Antinori","year":"2003","unstructured":"Antinori A, Cingolani A, Lorenzini P, Giancola ML, Uccella I, Bossolasco S, Grisetti S, Moretti F, Vigo B, Bongiovanni M, Del Grosso B, Arcidiacono MI, Fibbia GC, Mena M, Finazzi MG, Guaraldi G, Ammassari A, d'Arminio Monforte A, Cinque P, De Luca A, for the Italian Registry Investigative Neuro AIDS (IRINA) Study Group (2003) Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: Data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 9 (Suppl 1):47\u201353","journal-title":"J Neurovirol"},{"key":"731_CR3","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/374048","volume":"36","author":"Berenguer","year":"2003","unstructured":"Berenguer J, Miralles P, Arrizabalaga J, Ribera E, Dronda F, Baraia-Etxaburu J, Domingo P, M\u00e1rquez M, Rodriguez- Arrondo FJ, Laguna F, Rubio R, Rodrigo JL, Mallolas J, de Miguel V, and the GESIDA 11\/99 Study Group (2003) Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin Infect Dis 36:1047\u20131052","journal-title":"Clin Infect Dis"},{"key":"731_CR4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11940-000-0053-7","volume":"2","author":"Berger","year":"2000","unstructured":"Berger JR (2000) Progressive multifocal leukoencephalopathy. Curr Treat Options Neurol 2:361\u2013368","journal-title":"Curr Treat Options Neurol"},{"key":"731_CR5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1212\/WNL.52.3.623","volume":"52","author":"Clifford","year":"1999","unstructured":"Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero P, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999) HAART improves prognosis in HIVassociated progressive multifocal leukoencephalopathy. Neurology 52:623\u2013625","journal-title":"Neurology"},{"key":"731_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.16.4.569-596.2003","volume":"16","author":"De Clercq","year":"2003","unstructured":"De Clercq E (2003) Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev 16:569\u2013596","journal-title":"Clin Microbiol Rev"},{"key":"731_CR7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","volume":"30","author":"De Clercq","year":"2004","unstructured":"De Clercq E (2004) Antiviral drugs in current clinical use. J Clin Virol 30:115\u2013133","journal-title":"J Clin Virol"},{"key":"731_CR8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1212\/WNL.52.4.891","volume":"52","author":"De Luca","year":"1999","unstructured":"De Luca A, Fantoni M, Tartaglione T, Antinori A (1999) Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 52:891\u2013892","journal-title":"Neurology"},{"key":"731_CR9","doi-asserted-by":"crossref","first-page":"F117","DOI":"10.1097\/00002030-200009290-00001","volume":"14","author":"De Luca","year":"2000","unstructured":"De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Paglia MG, Govoni A, Murri R, Testa L, d'Arminio Monforte A, Antinori A (2000) Cidofovir added to HAART improves virological and clinical outcome in AIDSassociated progressive multifocal leukoencephalopathy. AIDS 14:F117\u2013F121","journal-title":"AIDS"},{"key":"731_CR10","first-page":"364","volume":"7","author":"De Luca","year":"2001","unstructured":"De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Larussa D, Alba L, Murri R, Ippolito G, Cauda R, d'Arminio Monforte A, Antinori A (2001) Potent anti-retroviral therapy with or without cidofovir for AIDSassociated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study. J Neuro Virol 7:364\u2013368","journal-title":"J Neuro Virol"},{"key":"731_CR11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1096-9071(199803)54:3<196::AID-JMV10>3.0.CO;2-G","volume":"54","author":"D\u00f6rries","year":"1998","unstructured":"D\u00f6rries K, Arendt G, Eggers C, RoggendorfW, D\u00f6rries R (1998) Nucleic acid detection as a diagnostic tool in polyomavirus JC induced progressive multifocal leukoencephalopathy. J Med Virol 54:196\u2013203","journal-title":"J Med Virol"},{"key":"731_CR12","first-page":"375","volume":"7","author":"Gasnault","year":"2001","unstructured":"Gasnault J, Kousignian P, Kahraman M, Rahoiljaon J, Matheron S, Delfraissy JF, Taoufik Y (2001) Cidofovir in AIDSassociated progressive multifocal leukoencephalopathy: A monocenter observational study with clinical and JC virus load monitoring. J Neuro Virol 7:375\u2013381","journal-title":"J Neuro Virol"},{"key":"731_CR13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/13550289909029483","volume":"5","author":"Gasnault","year":"1999","unstructured":"Gasnault J, Taoufik Y, Goujard C, Kousignian P, Abbed K, Boue F, Dussaix E, Delfraissy JF (1999) Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy. J NeuroVirol 5:421\u2013429","journal-title":"J NeuroVirol"},{"key":"731_CR14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s001150050601","volume":"70","author":"Happe","year":"1999","unstructured":"Happe S, Besselmann M, Matheja P, Rickert CH, Schuierer G, Reichelt D, Husstedt IW (1999) Cidofovir (Vistide) in der Therapie der Progressiven Multifokalen Leukoenzephalopathie (PML) bei AIDS. Nervenarzt 70:935\u2013943","journal-title":"Nervenarzt"},{"key":"731_CR15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s001150050014","volume":"71","author":"Happe","year":"2000","unstructured":"Happe S, L\u00fcnenborg N, Rickert CH, Heese C, Reichelt D, Schuierer G, Schul C, Husstedt IW (2000) Progressive multifokale Leukoenzephalopathie im Verlauf der AIDS-Erkrankung. \u00dcbersicht und retrospektive Analyse von 17 Patienten. Nervenarzt 71:96\u2013104","journal-title":"Nervenarzt"},{"key":"731_CR16","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1212\/WNL.41.12.1967","volume":"41","author":"Henson","year":"1991","unstructured":"Henson J, Rosenblum M, Armstrong D, Furneaux H (1991) Amplification of JC virus DNA from brain and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. Neurology 41:1967\u20131971","journal-title":"Neurology"},{"key":"731_CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/13550289809114545","volume":"4","author":"Hou","year":"1998","unstructured":"Hou J, Major EO (1998) The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J Neurovirol 4:451\u2013456","journal-title":"J Neurovirol"},{"key":"731_CR18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00019052-200406000-00019","volume":"17","author":"Koralnik","year":"2004","unstructured":"Koralnik IJ (2004) New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 17:365\u2013370","journal-title":"Curr Opin Neurol"},{"key":"731_CR19","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1097\/00002030-200209060-00012","volume":"16","author":"Marra","year":"2002","unstructured":"Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford D, Post MJD, Ruiz A, Bowen BC, Huang ML, Queen-Baker J, Andersen J, Kelly S, Shriver S, and the Adult AIDS Clinical Trials Group 363 Team (2002) A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 16:1791\u20131797","journal-title":"AIDS"},{"key":"731_CR20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000008046","volume":"41","author":"Meylan","year":"1999","unstructured":"Meylan PRA, Vuadens P, Maeder P, Sahli R, Tagan MC (1999) Monitoring the response of AIDS-related progressive multifocal leukoencephalopathy to HAART and cidofovir by PCR for JC virus DNA in the CSF. Eur Neurol 41:172\u2013174","journal-title":"Eur Neurol"},{"key":"731_CR21","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/JCM.31.12.3310-3313.1993","volume":"31","author":"Moret","year":"1993","unstructured":"Moret H, Guichard M, Matheron S, Katlama C, Sazdovitch V, Huraux JM, Ingrand D (1993) Virological diagnosis of progressive multifocal leukoencephalopathy: Detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients. J Clin Microbiol 31:3310\u20133313","journal-title":"J Clin Microbiol"},{"key":"731_CR22","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.4065\/76.11.1171","volume":"76","author":"Razonable","year":"2001","unstructured":"Razonable RR, Aksamit AJ, Wright AJ, Wilson JW (2001) Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin Proc 76:1171\u20131175","journal-title":"Mayo Clin Proc"},{"key":"731_CR23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/jnnp.2004.057588","volume":"76","author":"Reilmann","year":"2005","unstructured":"Reilmann R, Imai T, Ringelstein EB, Gaubitz M, Niederstadt TU, Paulus W, Husstedt IW (2005) Remission of progressive multifocal leukoencephalopathy in SLE after treatment with cidofovir: a 4 year follow up. J Neurol Neurosurg Psychiatry 76:1304\u20131305","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"731_CR24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0924-8579(02)00393-X","volume":"21","author":"Roberts","year":"2003","unstructured":"Roberts MTM, Carmichael A, Lever AML (2003) Prolonged survival in AIDS-related progressive multifocal leukoencephalopathy following antiretroviral therapy and cidofovir. Int J Antimicrob Agents 21:347\u2013349","journal-title":"Int J Antimicrob Agents"},{"key":"731_CR25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1345\/aph.10338","volume":"35","author":"Segarra-Newnham","year":"2001","unstructured":"Segarra-Newnham M, Vodolo KM (2001) Use of cidofovir in progressive multifocal leukoencephalopathy. Ann Pharmacother 35:741\u2013744","journal-title":"Ann Pharmacother"},{"key":"731_CR26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/324350","volume":"34","author":"Skiest","year":"2002","unstructured":"Skiest DJ (2002) Focal neurological disease in patients with acquired immunodeficiency syndrome. Clin Infect Dis 34:103\u2013115","journal-title":"Clin Infect Dis"},{"key":"731_CR27","first-page":"1561","volume":"3","author":"Snoeck","year":"2002","unstructured":"Snoeck R, De Clercq E (2002) Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients. Curr Opin Investig Drugs 3:1561\u20131566","journal-title":"Curr Opin Investig Drugs"},{"key":"731_CR28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/BF03045050","volume":"94","author":"Wasmuth","year":"1998","unstructured":"Wasmuth JC, Wasmuth-Pietzich A, Spengler U, Rockstroh J (1998) Die progressive multifokale Leukoenzephalopathie. Med Klin 94:264\u2013273","journal-title":"Med Klin"},{"key":"731_CR29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2004-833181","volume":"31","author":"Weber","year":"2004","unstructured":"Weber F, L\u00fcke W, Weber T (2004) Die progressive multifokale Leukoenzephalopathie (PML) \u2013 Diagnose, Pathogenese und Therapieoptionen. Akt Neurol 31:19\u201326","journal-title":"Akt Neurol"},{"key":"731_CR30","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/01.qai.0000136093.47316.f3","volume":"37","author":"Wyen","year":"2004","unstructured":"Wyen C, Hoffmann C, Schmei\u00dfer N, W\u00f6hrmann A, Qurishi N, Rockstroh J, Esser S, Rieke A, Ross B, Lorenzen T, Schmitz K, Stenzel W, Salzberger B, F\u00e4tkenheuer G (2004) Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy. Survival and risk factors of death. J Acquir Immune Defic Syndr 37:1263\u20131268","journal-title":"J Acquir Immune Defic Syndr"},{"key":"731_CR31","first-page":"190","volume":"6","author":"Zimmermann","year":"2001","unstructured":"Zimmermann T, Stingele K, Hartmann M, Haas J, von Einsiedel R, Wildemann B (2001) Successful treatment of AIDS related PML with HAART and cidofovir. Eur J Med Res 6:190\u2013192","journal-title":"Eur J Med Res"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-0731-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-008-0731-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-0731-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T21:46:23Z","timestamp":1588283183000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-008-0731-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,18]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["731"],"URL":"https:\/\/doi.org\/10.1007\/s00415-008-0731-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,18]]}}}